| - Industry | - Sector | - CEO | HKEX Exchange | - ISIN |
| Hong Kong Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
CSPC Pharmaceutical Group Ltd. stands as a pioneering and influential entity within the pharmaceutical sphere, primarily focusing on research, development, manufacturing, and distribution of an extensive assortment of pharmaceutical products. As a major participant, CSPC Pharmaceutical caters to various healthcare necessities through its broad portfolio, which encompasses innovative drugs, generics, and over-the-counter (OTC) medications. The company is notably active in therapeutic areas such as cardiovascular, oncology, anti-infectives, and nervous system treatments, significantly contributing to improved health outcomes. With its headquarters in China, CSPC Pharmaceutical is a leader in pharmaceutical advancements, dedicating considerable investment in research and development to promote the creation of innovative therapies. Its considerable market presence and strategic partnerships highlight its impact in the Asian markets and internationally. CSPC Pharmaceutical’s dedication to quality, affordability, and accessibility of healthcare solutions mirrors its ambition to enhance lives and further healthcare advancements worldwide.